Concepts (218)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Dopamine | 14 | 2021 | 277 | 3.660 |
Why?
|
| Corpus Striatum | 7 | 2024 | 89 | 2.690 |
Why?
|
| Learning | 7 | 2019 | 287 | 1.570 |
Why?
|
| Dopaminergic Neurons | 3 | 2021 | 26 | 1.430 |
Why?
|
| Mesencephalon | 2 | 2021 | 64 | 1.380 |
Why?
|
| Receptors, Dopamine D2 | 4 | 2019 | 57 | 1.370 |
Why?
|
| Motor Activity | 9 | 2019 | 326 | 1.370 |
Why?
|
| Reward | 5 | 2021 | 197 | 1.310 |
Why?
|
| Behavior, Animal | 6 | 2021 | 383 | 1.310 |
Why?
|
| Mice, Inbred C57BL | 13 | 2024 | 3273 | 1.140 |
Why?
|
| Obesity | 5 | 2024 | 974 | 1.090 |
Why?
|
| Motivation | 3 | 2019 | 303 | 1.010 |
Why?
|
| Synapses | 3 | 2024 | 280 | 1.000 |
Why?
|
| Neuronal Plasticity | 5 | 2024 | 194 | 0.940 |
Why?
|
| Diet, High-Fat | 1 | 2024 | 121 | 0.880 |
Why?
|
| Energy Metabolism | 4 | 2019 | 287 | 0.830 |
Why?
|
| Signal Transduction | 6 | 2019 | 3426 | 0.830 |
Why?
|
| Parkinson Disease | 3 | 2013 | 151 | 0.800 |
Why?
|
| Self Stimulation | 1 | 2021 | 3 | 0.770 |
Why?
|
| Food Deprivation | 1 | 2021 | 24 | 0.770 |
Why?
|
| Feeding Behavior | 2 | 2015 | 330 | 0.720 |
Why?
|
| Globus Pallidus | 2 | 2017 | 19 | 0.680 |
Why?
|
| Adenylyl Cyclases | 7 | 2011 | 102 | 0.680 |
Why?
|
| Anorexia Nervosa | 1 | 2020 | 142 | 0.630 |
Why?
|
| Mice | 20 | 2024 | 11932 | 0.630 |
Why?
|
| Nicotine | 2 | 2017 | 202 | 0.610 |
Why?
|
| Animals | 30 | 2024 | 27690 | 0.610 |
Why?
|
| High Fructose Corn Syrup | 1 | 2017 | 1 | 0.600 |
Why?
|
| Metabolic Diseases | 1 | 2017 | 52 | 0.560 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2017 | 88 | 0.540 |
Why?
|
| Cerebral Cortex | 2 | 2017 | 592 | 0.480 |
Why?
|
| Neural Pathways | 3 | 2017 | 319 | 0.480 |
Why?
|
| Mice, Transgenic | 6 | 2021 | 1583 | 0.460 |
Why?
|
| Substantia Nigra | 2 | 2013 | 29 | 0.420 |
Why?
|
| Nutritive Value | 1 | 2012 | 6 | 0.410 |
Why?
|
| Body Weight | 4 | 2017 | 455 | 0.400 |
Why?
|
| Taste | 1 | 2012 | 28 | 0.400 |
Why?
|
| Eating | 1 | 2011 | 168 | 0.360 |
Why?
|
| Dopamine Agents | 1 | 2010 | 28 | 0.350 |
Why?
|
| Levodopa | 1 | 2010 | 37 | 0.340 |
Why?
|
| Movement Disorders | 1 | 2010 | 44 | 0.340 |
Why?
|
| Motor Skills | 1 | 2010 | 79 | 0.330 |
Why?
|
| Homeostasis | 1 | 2011 | 424 | 0.330 |
Why?
|
| Dietary Sucrose | 1 | 2008 | 13 | 0.310 |
Why?
|
| Cocaine | 2 | 2010 | 77 | 0.310 |
Why?
|
| Weight Gain | 1 | 2008 | 120 | 0.290 |
Why?
|
| Family | 2 | 1999 | 324 | 0.290 |
Why?
|
| Sucrose | 3 | 2012 | 65 | 0.270 |
Why?
|
| Basal Ganglia | 2 | 2019 | 46 | 0.250 |
Why?
|
| Male | 15 | 2024 | 42909 | 0.250 |
Why?
|
| Biological Clocks | 1 | 2006 | 74 | 0.250 |
Why?
|
| Escherichia coli Proteins | 2 | 2004 | 183 | 0.240 |
Why?
|
| Protein Subunits | 1 | 2004 | 123 | 0.230 |
Why?
|
| Chromatography, Affinity | 1 | 2004 | 81 | 0.220 |
Why?
|
| Cytoplasm | 1 | 2004 | 285 | 0.220 |
Why?
|
| Receptors, Nicotinic | 2 | 2016 | 132 | 0.220 |
Why?
|
| Mice, Knockout | 5 | 2019 | 2033 | 0.220 |
Why?
|
| Escherichia coli | 2 | 2004 | 611 | 0.220 |
Why?
|
| Circadian Rhythm | 1 | 2006 | 305 | 0.210 |
Why?
|
| Neurons | 3 | 2024 | 1593 | 0.210 |
Why?
|
| Peptide Fragments | 1 | 2004 | 465 | 0.210 |
Why?
|
| Saccharin | 2 | 2012 | 9 | 0.200 |
Why?
|
| Female | 11 | 2021 | 46831 | 0.200 |
Why?
|
| Isoenzymes | 4 | 2010 | 275 | 0.200 |
Why?
|
| Disease Models, Animal | 3 | 2020 | 2407 | 0.200 |
Why?
|
| Cyclic AMP | 3 | 2014 | 278 | 0.190 |
Why?
|
| Appetitive Behavior | 2 | 2012 | 15 | 0.190 |
Why?
|
| Glucose | 2 | 2017 | 633 | 0.180 |
Why?
|
| Anorexia | 1 | 2020 | 28 | 0.180 |
Why?
|
| Central Nervous System Stimulants | 3 | 2011 | 220 | 0.170 |
Why?
|
| Verbal Behavior | 1 | 1999 | 32 | 0.170 |
Why?
|
| Social Adjustment | 1 | 1999 | 47 | 0.170 |
Why?
|
| Homosexuality, Female | 1 | 1999 | 15 | 0.170 |
Why?
|
| Cues | 2 | 2011 | 175 | 0.170 |
Why?
|
| Excitatory Postsynaptic Potentials | 2 | 2017 | 88 | 0.170 |
Why?
|
| Health Services for the Aged | 1 | 1999 | 32 | 0.160 |
Why?
|
| Association Learning | 2 | 2010 | 34 | 0.160 |
Why?
|
| Costs and Cost Analysis | 1 | 2019 | 153 | 0.160 |
Why?
|
| Conditioning, Operant | 3 | 2015 | 71 | 0.160 |
Why?
|
| Mental Health Services | 1 | 1999 | 59 | 0.160 |
Why?
|
| Long-Term Care | 1 | 1999 | 62 | 0.160 |
Why?
|
| Truth Disclosure | 1 | 1999 | 92 | 0.160 |
Why?
|
| Nucleus Accumbens | 3 | 2011 | 113 | 0.150 |
Why?
|
| Caregivers | 1 | 1999 | 170 | 0.150 |
Why?
|
| Prefrontal Cortex | 1 | 2019 | 137 | 0.140 |
Why?
|
| Social Support | 1 | 1999 | 219 | 0.140 |
Why?
|
| Organ Culture Techniques | 1 | 2017 | 135 | 0.140 |
Why?
|
| Homosexuality, Male | 1 | 1999 | 306 | 0.130 |
Why?
|
| Rats, Sprague-Dawley | 4 | 2012 | 1240 | 0.130 |
Why?
|
| Calorimetry, Indirect | 1 | 2015 | 14 | 0.130 |
Why?
|
| Amphetamine | 2 | 2011 | 103 | 0.130 |
Why?
|
| Mice, 129 Strain | 1 | 2015 | 56 | 0.120 |
Why?
|
| Homeodomain Proteins | 2 | 2010 | 558 | 0.120 |
Why?
|
| Housing, Animal | 1 | 2015 | 46 | 0.120 |
Why?
|
| Neostriatum | 1 | 2014 | 26 | 0.110 |
Why?
|
| Choice Behavior | 1 | 2015 | 162 | 0.110 |
Why?
|
| Dopamine Plasma Membrane Transport Proteins | 2 | 2011 | 37 | 0.110 |
Why?
|
| Neurons, Afferent | 1 | 2014 | 79 | 0.110 |
Why?
|
| Solubility | 2 | 2004 | 185 | 0.110 |
Why?
|
| Rotarod Performance Test | 2 | 2010 | 9 | 0.110 |
Why?
|
| Phenotype | 1 | 2020 | 2467 | 0.110 |
Why?
|
| Conditioning, Classical | 2 | 2011 | 36 | 0.110 |
Why?
|
| Dopamine D2 Receptor Antagonists | 1 | 2012 | 7 | 0.110 |
Why?
|
| Exercise Therapy | 1 | 2013 | 86 | 0.100 |
Why?
|
| Sweetening Agents | 1 | 2012 | 17 | 0.100 |
Why?
|
| Rats | 4 | 2012 | 4059 | 0.100 |
Why?
|
| Food Preferences | 1 | 2012 | 27 | 0.100 |
Why?
|
| Reaction Time | 2 | 2010 | 311 | 0.100 |
Why?
|
| Antiparkinson Agents | 1 | 2011 | 16 | 0.100 |
Why?
|
| Blood Glucose | 1 | 2015 | 846 | 0.090 |
Why?
|
| Food | 1 | 2011 | 89 | 0.090 |
Why?
|
| Transcription Factors | 2 | 2010 | 1673 | 0.090 |
Why?
|
| Gene Knockdown Techniques | 1 | 2011 | 252 | 0.090 |
Why?
|
| Psychotropic Drugs | 1 | 2011 | 79 | 0.090 |
Why?
|
| Dronabinol | 1 | 2011 | 56 | 0.090 |
Why?
|
| Exercise | 1 | 2013 | 328 | 0.090 |
Why?
|
| Analysis of Variance | 2 | 2010 | 898 | 0.080 |
Why?
|
| Adenosine | 1 | 2012 | 242 | 0.080 |
Why?
|
| Benzazepines | 1 | 2010 | 64 | 0.080 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2011 | 1935 | 0.080 |
Why?
|
| Humans | 11 | 2019 | 90539 | 0.080 |
Why?
|
| Physical Conditioning, Animal | 1 | 2008 | 19 | 0.080 |
Why?
|
| Cognition | 1 | 2013 | 587 | 0.080 |
Why?
|
| Tyrosine 3-Monooxygenase | 1 | 2008 | 44 | 0.080 |
Why?
|
| Energy Intake | 1 | 2008 | 98 | 0.080 |
Why?
|
| Mice, Mutant Strains | 1 | 2008 | 231 | 0.070 |
Why?
|
| Action Potentials | 2 | 2013 | 602 | 0.070 |
Why?
|
| Adenylyl Cyclase Inhibitors | 2 | 2004 | 10 | 0.070 |
Why?
|
| Space Perception | 1 | 2008 | 117 | 0.070 |
Why?
|
| Regression Analysis | 1 | 2008 | 591 | 0.070 |
Why?
|
| Genotype | 1 | 2011 | 1855 | 0.070 |
Why?
|
| Immunohistochemistry | 2 | 2008 | 1805 | 0.070 |
Why?
|
| Circular Dichroism | 2 | 2004 | 117 | 0.070 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2015 | 2362 | 0.070 |
Why?
|
| Darkness | 1 | 2006 | 49 | 0.070 |
Why?
|
| Exploratory Behavior | 1 | 2006 | 48 | 0.060 |
Why?
|
| Cell Fusion | 1 | 2005 | 39 | 0.060 |
Why?
|
| Psychological Tests | 1 | 2006 | 91 | 0.060 |
Why?
|
| Body Temperature | 1 | 2006 | 125 | 0.060 |
Why?
|
| Endopeptidase K | 1 | 2004 | 12 | 0.060 |
Why?
|
| Spectrum Analysis, Raman | 1 | 2004 | 15 | 0.060 |
Why?
|
| Enzyme Activators | 1 | 2004 | 14 | 0.060 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gs | 1 | 2004 | 19 | 0.060 |
Why?
|
| Amino Acid Sequence | 3 | 2004 | 2076 | 0.060 |
Why?
|
| Light | 1 | 2006 | 292 | 0.060 |
Why?
|
| Hydrolysis | 1 | 2004 | 147 | 0.060 |
Why?
|
| Models, Biological | 1 | 2011 | 1770 | 0.060 |
Why?
|
| Conserved Sequence | 1 | 2004 | 211 | 0.060 |
Why?
|
| Molecular Sequence Data | 3 | 2004 | 3029 | 0.060 |
Why?
|
| Protein Structure, Secondary | 1 | 2004 | 335 | 0.060 |
Why?
|
| Photic Stimulation | 1 | 2006 | 502 | 0.050 |
Why?
|
| Protein Structure, Tertiary | 1 | 2004 | 742 | 0.050 |
Why?
|
| Time Factors | 1 | 2010 | 5364 | 0.050 |
Why?
|
| Peptidylprolyl Isomerase | 1 | 2000 | 9 | 0.050 |
Why?
|
| Receptors, Metabotropic Glutamate | 1 | 2000 | 51 | 0.040 |
Why?
|
| Institutionalization | 1 | 1999 | 5 | 0.040 |
Why?
|
| Carrier Proteins | 1 | 2000 | 680 | 0.040 |
Why?
|
| Synaptic Potentials | 1 | 2016 | 15 | 0.030 |
Why?
|
| Brain | 1 | 2006 | 2317 | 0.030 |
Why?
|
| In Vitro Techniques | 2 | 2014 | 997 | 0.030 |
Why?
|
| Nicotinic Agonists | 1 | 2016 | 75 | 0.030 |
Why?
|
| Receptors, Platelet-Derived Growth Factor | 1 | 1995 | 17 | 0.030 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 1995 | 80 | 0.030 |
Why?
|
| Zinc | 1 | 1995 | 96 | 0.030 |
Why?
|
| Electrophysiological Phenomena | 1 | 2014 | 51 | 0.030 |
Why?
|
| Long-Term Potentiation | 1 | 2014 | 48 | 0.030 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 1995 | 159 | 0.030 |
Why?
|
| MPTP Poisoning | 1 | 2013 | 3 | 0.030 |
Why?
|
| Dendritic Spines | 1 | 2013 | 15 | 0.030 |
Why?
|
| Exocytosis | 1 | 2013 | 109 | 0.030 |
Why?
|
| Patch-Clamp Techniques | 1 | 2014 | 397 | 0.030 |
Why?
|
| Electric Stimulation | 1 | 2014 | 365 | 0.030 |
Why?
|
| Goals | 1 | 2013 | 67 | 0.030 |
Why?
|
| Neurogenesis | 1 | 2013 | 78 | 0.030 |
Why?
|
| Apomorphine | 1 | 2011 | 10 | 0.020 |
Why?
|
| Dopamine Agonists | 1 | 2011 | 27 | 0.020 |
Why?
|
| Self Administration | 1 | 2011 | 72 | 0.020 |
Why?
|
| Health Status | 1 | 2013 | 370 | 0.020 |
Why?
|
| Rats, Long-Evans | 1 | 2011 | 50 | 0.020 |
Why?
|
| Calcium | 1 | 1995 | 1182 | 0.020 |
Why?
|
| Dopamine Uptake Inhibitors | 1 | 2010 | 44 | 0.020 |
Why?
|
| United States | 1 | 1999 | 7138 | 0.020 |
Why?
|
| Cell Shape | 1 | 2005 | 51 | 0.020 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2005 | 73 | 0.020 |
Why?
|
| Catalytic Domain | 1 | 2005 | 159 | 0.020 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2005 | 108 | 0.020 |
Why?
|
| Antigens, Bacterial | 1 | 2005 | 136 | 0.020 |
Why?
|
| Bacterial Toxins | 1 | 2005 | 115 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2006 | 794 | 0.010 |
Why?
|
| Cricetinae | 1 | 2005 | 560 | 0.010 |
Why?
|
| DNA Primers | 1 | 2005 | 546 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2008 | 1741 | 0.010 |
Why?
|
| Transfection | 1 | 2005 | 910 | 0.010 |
Why?
|
| Aged | 1 | 1999 | 19380 | 0.010 |
Why?
|
| Base Sequence | 1 | 2005 | 2329 | 0.010 |
Why?
|
| Cell Line | 1 | 2005 | 2505 | 0.010 |
Why?
|
| Dimerization | 1 | 2000 | 143 | 0.010 |
Why?
|
| Benzoates | 1 | 2000 | 33 | 0.010 |
Why?
|
| Glutamates | 1 | 2000 | 88 | 0.010 |
Why?
|
| Indans | 1 | 2000 | 35 | 0.010 |
Why?
|
| Excitatory Amino Acid Antagonists | 1 | 2000 | 80 | 0.010 |
Why?
|
| Glycine | 1 | 2000 | 98 | 0.010 |
Why?
|
| Middle Aged | 1 | 1999 | 26305 | 0.010 |
Why?
|
| Adult | 1 | 1999 | 26922 | 0.010 |
Why?
|
| Phosphatidylinositols | 1 | 1995 | 20 | 0.010 |
Why?
|
| Cations, Divalent | 1 | 1995 | 39 | 0.010 |
Why?
|
| Subtilisins | 1 | 1995 | 27 | 0.010 |
Why?
|
| Oncogene Proteins, Viral | 1 | 1995 | 33 | 0.010 |
Why?
|
| Binding, Competitive | 1 | 1995 | 146 | 0.010 |
Why?
|
| Xenopus laevis | 1 | 1995 | 138 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 1995 | 419 | 0.010 |
Why?
|
| Oocytes | 1 | 1995 | 219 | 0.010 |
Why?
|
| Sequence Alignment | 1 | 1995 | 354 | 0.010 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 1995 | 269 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 1995 | 1015 | 0.010 |
Why?
|
| Binding Sites | 1 | 1995 | 1127 | 0.010 |
Why?
|
| Protein Conformation | 1 | 1995 | 898 | 0.010 |
Why?
|
| Protein Binding | 1 | 1995 | 1500 | 0.010 |
Why?
|